Akebia Therapeutics Q4 Earnings Report: What Investors Need to Know
Benzinga Insights 8 months ago
Earnings
Akebia Therapeutics (NASDAQ:AKBA) announced its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.
Here's a breakdown of the earnings report.
Earnings
Akebia Therapeutics missed estimated earnings by 0.0%, reporting an EPS of $-0.05 versus an estimate of $-0.05.
Revenue was up $11.12 million from the same period last year.
Earnings History Overview
The company beat on EPS by $0.02 in the last quarter, resulting in a 8.38% increase share price change the following day.
Here's a look at Akebia Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.02 | -0.02 | -0.04 | -0.08 |
| EPS Actual | 0 | 0 | 0.03 | -0.10 |
| Revenue Estimate | 57.46M | 47.06M | 44.88M | 37.36M |
| Revenue Actual | 58.77M | 62.47M | 57.34M | 46.50M |
To track all earnings releases for Akebia Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.